Publications by authors named "Mark Schenerman"

Claim this Profile
L
Lighting the match: how a student-led career mentorship program can blaze the way for non-academic careers.
Anna Bagnell, Alana MacDonald, Peter Espenshade, Mark Schenerman

Nat Biotechnol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal Antibody Dimers Induced by Low pH, Heat, or Light Exposure Are Not Immunogenic Upon Subcutaneous Administration in a Mouse Model.
Grzegorz Kijanka, Jared S Bee, Mark A Schenerman, Samuel A Korman, Yuling Wu

J Pharm Sci· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Submicron Size Particles of a Murine Monoclonal Antibody Are More Immunogenic Than Soluble Oligomers or Micron Size Particles Upon Subcutaneous Administration in Mice.
Grzegorz Kijanka, Jared S Bee, Samuel A Korman, Yuling Wu, Lorin K Roskos, Mark A Schenerman

J Pharm Sci· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of parallelism testing for four-parameter logistic model in bioassays.
Harry Yang, Hyun Jun Kim, Lanju Zhang, Robert J Strouse, Mark Schenerman

PDA J Pharm Sci Technol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A statistical approach to determining criticality of residual host cell DNA.
Harry Yang, Ziping Wei, Mark Schenerman

J Biopharm Stat· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved particle counting and size distribution determination of aggregated virus populations by asymmetric flow field-flow fractionation and multiangle light scattering techniques.
Matt McEvoy, Vladimir Razinkov, Ziping Wei, Jose R Casas-Finet, Guillermo I Tous, Mark A Schenerman

Biotechnol Prog· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a synthetic peptide as a replacement for the recombinant fusion protein of respiratory syncytial virus in a potency ELISA.
James B McGivney, Eric Bishop, Kenneth Miller, Jose Casas-Finet, Harry Yang, Mark Schenerman

J Pharm Biomed Anal· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in the assessment and control of the effector functions of therapeutic antibodies.
Xu-Rong Jiang, An Song, Svetlana Bergelson, Thomas Arroll, Bhavin Parekh, Mark Schenerman

Nat Rev Drug Discov· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biophysical characterization of influenza virus subpopulations using field flow fractionation and multiangle light scattering: correlation of particle counts, size distribution and infectivity.
Ziping Wei, Matt McEvoy, Vladimir Razinkov, Alla Polozova, Elizabeth Li, Mark A Schenerman

J Virol Methods· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a single tryptophan residue as critical for binding activity in a humanized monoclonal antibody against respiratory syncytial virus.
Ziping Wei, Jinhua Feng, Hung-Yu Lin, Sombabu Mullapudi, Eric Bishop, Mark A Schenerman

Anal Chem· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of a novel modification to monoclonal antibodies: thioether cross-link of heavy and light chains.
Guillermo I Tous, Ziping Wei, Jinhua Feng, Susanna Bilbulian, Stephen Bowen, Mark A Schenerman

Anal Chem· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis